These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25820840)

  • 1. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
    Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
    Furey ML; Drevets WC; Hoffman EM; Frankel E; Speer AM; Zarate CA
    JAMA Psychiatry; 2013 Mar; 70(3):280-90. PubMed ID: 23364679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
    Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):610-618. PubMed ID: 30826253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder.
    Szczepanik J; Nugent AC; Drevets WC; Khanna A; Zarate CA; Furey ML
    Psychiatry Res Neuroimaging; 2016 Aug; 254():67-73. PubMed ID: 27366831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in neural activity when processing emotional arousal and valence in autism spectrum disorders.
    Tseng A; Wang Z; Huo Y; Goh S; Russell JA; Peterson BS
    Hum Brain Mapp; 2016 Feb; 37(2):443-61. PubMed ID: 26526072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
    Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
    J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
    Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
    Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Ohman A; Drevets WC
    Arch Gen Psychiatry; 2010 Nov; 67(11):1128-38. PubMed ID: 21041614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alexithymia is associated with attenuated automatic brain response to facial emotion in clinical depression.
    Suslow T; Kugel H; Rufer M; Redlich R; Dohm K; Grotegerd D; Zaremba D; Dannlowski U
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():194-200. PubMed ID: 26482526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
    Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
    JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic mood-congruent amygdala responses to masked facial expressions in major depression.
    Suslow T; Konrad C; Kugel H; Rumstadt D; Zwitserlood P; Schöning S; Ohrmann P; Bauer J; Pyka M; Kersting A; Arolt V; Heindel W; Dannlowski U
    Biol Psychiatry; 2010 Jan; 67(2):155-60. PubMed ID: 19748075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Bellgowan PS; Öhman A; Drevets WC
    PLoS One; 2012; 7(10):e46439. PubMed ID: 23056309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amygdala and whole-brain activity to emotional faces distinguishes major depressive disorder and bipolar disorder.
    Fournier JC; Keener MT; Almeida J; Kronhaus DM; Phillips ML
    Bipolar Disord; 2013 Nov; 15(7):741-52. PubMed ID: 23911154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain activation predicts treatment improvement in patients with major depressive disorder.
    Samson AC; Meisenzahl E; Scheuerecker J; Rose E; Schoepf V; Wiesmann M; Frodl T
    J Psychiatr Res; 2011 Sep; 45(9):1214-22. PubMed ID: 21477817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early processing of emotional faces in a Go/NoGo task: lack of N170 right-hemispheric specialisation in children with major depression.
    Grunewald M; Stadelmann S; Brandeis D; Jaeger S; Matuschek T; Weis S; Kalex V; Hiemisch A; von Klitzing K; Döhnert M
    J Neural Transm (Vienna); 2015 Sep; 122(9):1339-52. PubMed ID: 26093649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective effects of cholinergic modulation on task performance during selective attention.
    Furey ML; Pietrini P; Haxby JV; Drevets WC
    Neuropsychopharmacology; 2008 Mar; 33(4):913-23. PubMed ID: 17534379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in neural responses to subliminal sad and happy faces in healthy individuals: Implications for depression.
    Victor TA; Drevets WC; Misaki M; Bodurka J; Savitz J
    J Neurosci Res; 2017 Jan; 95(1-2):703-710. PubMed ID: 27870414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score.
    Keedwell P; Drapier D; Surguladze S; Giampietro V; Brammer M; Phillips M
    J Psychopharmacol; 2009 Sep; 23(7):775-88. PubMed ID: 18635699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.